Shares of Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) saw unusually-high trading volume on Friday . Approximately 30,726 shares changed hands during mid-day trading, an increase of 1,551% from the previous session’s volume of 1,861 shares.The stock last traded at $0.7504 and had previously closed at $0.61.
Sino Biopharmaceutical Stock Up 15.3%
The company’s 50 day moving average is $0.62 and its 200-day moving average is $0.71.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Recommended Stories
- Five stocks we like better than Sino Biopharmaceutical
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
